Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyaluronic Acid as a Novel Therapeutic Approach for Patients With GERD: a Single-center Study

NCT05561179 is registered in ClinicalTrials.gov with Instituto Ecuatoriano de Enfermedades Digestivas as lead sponsor.

NCT NCT05561179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05561179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyaluronic Acid as a Novel Therapeutic Approach for Patients With GERD: a Single-center Study
Lead sponsor
Instituto Ecuatoriano de Enfermedades Digestivas
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2022
Completion date
September 30, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux